<--- Back to Details
First PageDocument Content
Biotechnology / Biology / Pharmacology / Biosimilar / Drugs / Biopharmaceutical / Orphan drug / Thommessen / Pharmaceutical industry in India
Date: 2015-09-23 06:21:01
Biotechnology
Biology
Pharmacology
Biosimilar
Drugs
Biopharmaceutical
Orphan drug
Thommessen
Pharmaceutical industry in India

ATTORNEY LISTINGS Advisory Judicial Review (Dispute Litigation)

Add to Reading List

Source URL: www.managingip.com

Download Document from Source Website

File Size: 276,38 KB

Share Document on Facebook

Similar Documents

Medical equipment / Eucomed / Medtech / Pharmaceutical industry in India / Pharmaceutical industry in China / Straumann / Business / Health

Microsoft PowerPoint - Helbling_MedTech_Study_2006_English.ppt

DocID: 1rlrr - View Document

Business / Biotechnology / Economy / Pharmacy / Pharmaceutical industry / Pharmaceuticals policy / Biopharmaceutical / Pharmaceutical industry in India / Novartis / Biosimilar / Boehringer Ingelheim / Teva Pharmaceutical Industries

January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

DocID: 1rlhw - View Document

Chemistry / Nature / Economy / Fine chemical / Organic chemistry / Pharmaceutical industry in China / Speciality chemicals / Innovation / Sustainability / Pharmaceutical industry in India

2015 annual report 2015 Annual Report

DocID: 1rbDn - View Document

Business / Economy / Biotechnology / CAC 40 / Sanofi / AstraZeneca / Novartis / Takeda Pharmaceutical Company / Valeant Pharmaceuticals / Pharmaceutical industry in China / Bausch & Lomb / Pharmaceutical industry in India

February 5, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum.  Sponsored By:

DocID: 1r6rO - View Document

Economy / Finance / Business / Celgene / Summit /  New Jersey / Versant / Venture capital / Atlas Venture / AstraZeneca / Pharmaceutical industry in India / Pharmaceutical industry in China

Here To Stay: Inception Sciences Shows Why Build-To-Buy Works By Marc Wortman (Contributor) January:15 AM Executive Summary

DocID: 1qW1m - View Document